Samantha P.

Samantha P. is an accomplished professional with extensive experience in business development and strategic planning within the biopharmaceutical industry. Currently serving as Executive Director and Head of Amgen Ventures at Amgen since February 2015, responsibilities include leading global search and evaluation efforts for therapeutic and technology assets in the Inflammation therapeutic area. Prior to this role, Samantha held several positions at Amgen, including Chief of Staff to the Chairman & CEO and Director for Search & Evaluation in Inflammation and Autoimmune Diseases. Earlier experience includes work as Global Project Manager and Principal Research Scientist at Innovimmune Biotherapeutics, where Samantha was instrumental in establishing laboratory operations and managing pre-clinical programs for autoimmune diseases. Academic credentials include a PhD in Immunology and Microbial Pathogenesis from Cornell University, an MBA from The Wharton School, and a BSc in Biochemistry from Ithaca College. Additional training includes a certificate in the Idea to IPO - Technology Venture Course from the New York Academy of Sciences.